Pfizer: “Pfizer and BioNTech Announce Constructive Topline Outcomes From Pivotal Trial of COVID-19 Vaccine in Kids 5 to 11 Years.”
Enterprise Wire: “Pfizer and BioNTech Submit Preliminary Information to U.S. FDA From Pivotal Trial of COVID-19 Vaccine in Kids 5 to <12 Years of Age.”
MSNBC: “Fauci reacts to Pfizer information: We hopefully shall be vaccinating youngsters ‘by the tip of October.’”
Gallup: “In U.S., 55% Would Get COVID-19 Vaccine for Younger Little one.”
The New York Occasions: “The F.D.A. once more warns dad and mom to not get youngsters underneath 12 vaccinated but.”
American Academy of Pediatrics: “AAP: Don’t use COVID-19 vaccine off-label for youngsters.”
Daybreak G., Missouri.
Carrie S., California.
Anne Liu, MD, scientific affiliate professor, Division of Medication, Division of Infectious Ailments, and Division of Pediatrics, Division of Allergy, Immunology, and Rheumatology, Stanford College College of Medication.
Michael Smith, MD, professor of pediatrics and member, Duke Human Vaccine Institute, Duke College College of Medication.